Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K C Lasseter

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Clinical Pharmacology and Therapeutics|June 1, 1989
The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacinR W Frost, J T Lettieri, G Krol, et al.
Clinical Pharmacology and Therapeutics|November 4, 2000
Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatinA L Mazzu, K C Lasseter, E C Shamblen, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1992
Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacinR W Frost, K C Lasseter, A J Noe, et al.
Journal of Clinical Pharmacology|May 20, 1998
Pharmacokinetics and pharmacodynamics of irbesartan in patients with hepatic cirrhosisM R Marino, K M Langenbacher, R H Raymond, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 1, 1991
The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral doseF Waldmeier, G Kaiser, R Ackermann, et al.
Journal of Clinical Pharmacology|April 29, 1998
Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humansM T Marino, B G Schuster, R P Brueckner, et al.
Pharmacotherapy|May 1, 1986
Once- and twice-daily nitrendipine in patients with hypertension and noninsulin-dependent diabetesT C Fagan, E B Nelson, K C Lasseter, et al.
Journal of Clinical Pharmacology|February 1, 1995
Single-dose and steady-state pharmacokinetics of fosinopril and fosinoprilat in patients with hepatic impairmentN F Ford, K C Lasseter, D R Van Harken, et al.
Journal of Clinical Pharmacology|September 2, 1998
Pharmacokinetics and pharmacodynamics of zolmitriptan in patients with mild to moderate hypertension: a double-blind, placebo-controlled studyD A Smith, E W Cleary, S Watkins, et al.
European Journal of Clinical Pharmacology|March 1, 2003
Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairmentS G Simonson, P D Martin, P Mitchell, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Clinical Pharmacology and Therapeutics|June 1, 1989
The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacinR W Frost, J T Lettieri, G Krol, et al.
Clinical Pharmacology and Therapeutics|November 4, 2000
Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatinA L Mazzu, K C Lasseter, E C Shamblen, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1992
Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacinR W Frost, K C Lasseter, A J Noe, et al.
Journal of Clinical Pharmacology|May 20, 1998
Pharmacokinetics and pharmacodynamics of irbesartan in patients with hepatic cirrhosisM R Marino, K M Langenbacher, R H Raymond, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 1, 1991
The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral doseF Waldmeier, G Kaiser, R Ackermann, et al.
Journal of Clinical Pharmacology|April 29, 1998
Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humansM T Marino, B G Schuster, R P Brueckner, et al.
Pharmacotherapy|May 1, 1986
Once- and twice-daily nitrendipine in patients with hypertension and noninsulin-dependent diabetesT C Fagan, E B Nelson, K C Lasseter, et al.
Journal of Clinical Pharmacology|February 1, 1995
Single-dose and steady-state pharmacokinetics of fosinopril and fosinoprilat in patients with hepatic impairmentN F Ford, K C Lasseter, D R Van Harken, et al.
Journal of Clinical Pharmacology|September 2, 1998
Pharmacokinetics and pharmacodynamics of zolmitriptan in patients with mild to moderate hypertension: a double-blind, placebo-controlled studyD A Smith, E W Cleary, S Watkins, et al.
European Journal of Clinical Pharmacology|March 1, 2003
Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairmentS G Simonson, P D Martin, P Mitchell, et al.
Pageof 6